Sofiva Genomics Co., Ltd. (6615) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sofiva Genomics Co., Ltd. (6615:TWSE), powered by AI.

Current Price
$34.60
Sector
Healthcare
What is the Sofiva Genomics Co., Ltd. stock price forecast?

Sofiva Genomics Co., Ltd. is currently trading at $34.60. View real-time AI analysis on Alpha Lenz.

What is Sofiva Genomics Co., Ltd. insider trading activity?

View the latest insider trading data for Sofiva Genomics Co., Ltd. on Alpha Lenz.

What is Sofiva Genomics Co., Ltd.'s P/E ratio?

View Sofiva Genomics Co., Ltd.'s valuation metrics on Alpha Lenz.

Sofiva Genomics Co., Ltd.

TWSE · 6615
NT$34.60-0.05(-0.14%)
Ask about Sofiva Genomics Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Sofiva Genomics Co., Ltd.'s ROE is -1.5%. Explore profitability and growth together.

Ask for details

Company Overview

Sofiva Genomics Co., Ltd. is a Taiwan-based provider of medical and genetic testing services, specializing in pre-pregnancy, prenatal, and newborn genetic diagnostics. Established in 2012 and headquartered in Taipei, the company focuses on advanced reproductive medicine, cancer genomics, rare disease screening, and personalized genetic analyses, serving hospitals, clinics, and individual clients. Its offerings include pre-implantation genetic diagnosis, predictive testing for preeclampsia, neonatal screenings for hearing loss and congenital infections, as well as panels for chronic diseases and cancer susceptibility. Sofiva Genomics plays a vital role in enabling precision medicine and preventive healthcare in the region, combining laboratory expertise with genetic counseling services to support informed health decisions. As part of Taiwan’s dynamic biotechnology and medical research sector, the company contributes to innovation in genetic testing, helping advance population health and healthcare efficiency through its specialized diagnostics and research-driven approach.

CEOMr. Yi-Ning Su
SectorHealthcare
IndustryDiagnostics & Research
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$385.71MRevenue
0.00Shares Out
0Employees

Margins

25.70%Gross
8.86%EBITDA
-8.74%Operating
-2.15%Pre-Tax
-2.30%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-8.03%Rev 3Yr
-4.63%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-1.19%ROA
-1.47%ROE
-1.00%ROIC

Financial Health

NT$90.61MCash & Cash Equivalents
NT$5.30MNet Debt
15.26%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Sofiva Genomics Co., Ltd. (ticker: 6615) is a company listed on TWSE in the Healthcare sector (Diagnostics & Research).

The current price is 34.6 with a P/E ratio of -x and P/B of -x.

ROE is -1.47% and operating margin is -8.74%. Annual revenue is $386M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Sofiva Genomics Co., Ltd. (6615) Stock Forecast 2026 $34.60 — Price, Financials & Analyst Targets | Alpha Lenz